Clinical Trial Update: Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing empagliflozin to sitagliptin for improvement of myocardial perfusion reserve in diabetic patients with coronary artery disease; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: CHEOL WHAN LEE, M.D., Ph.D | Conditions: Diabetes Mellitus, Coronary Disease | Phase 4 | Status: COMPLETED